selenium and breast cancer

Release time ：Dec-22,2024

Selenium, a trace element, is crucial for human health. Research indicates a possible link between selenium and the incidence and progression of breast cancer, though this association is not definitive and is subject to various influencing factors.

As an antioxidant, selenium can combat cell damage and inflammation, potentially reducing the risk of cancer. Studies have revealed that individuals with higher selenium levels in their blood tend to have a lower prevalence of breast cancer. Moreover, selenium may inhibit tumor growth and spread by modulating the cell cycle and promoting apoptosis.

It's important to recognize that excessive selenium intake can be detrimental and may even heighten the risk of certain cancers. Therefore, selenium supplementation should be moderate to prevent overconsumption. Given the significant inter-individual variability, selenium requirements differ among populations, and supplementation should ideally be guided by a healthcare professional.

In conclusion, the relationship between selenium and breast cancer is intricate, offering both potential benefits and risks. For health preservation, it is advisable to supplement selenium sensibly under medical supervision and to engage in regular breast cancer screening.